Core Viewpoint - Xizang Pharmaceutical emphasizes the significance of in vivo gene editing technology as a major breakthrough in life sciences, offering revolutionary treatment options beyond hereditary diseases, including metabolic, infectious diseases, and cancer [1] Group 1: In Vivo Gene Editing - In vivo gene editing allows for precise modifications to the genome, enabling knockouts, knockdowns, or insertions [1] - The technology presents substantial advantages in terms of efficacy, market potential, and cost-effectiveness, with the possibility of one-time cures [1] Group 2: Technological Platforms - Ruizheng Gene has established a comprehensive technology system with three major platforms: nucleic acid platform, gene editing platform, and delivery technology platform [1] - This end-to-end technology framework supports the full chain of gene editing processes [1]